title: After half-century's wait, approval paves path for new lupus drugs.
authors.forename: Heidi
authors.initials: H
authors.lastname: Ledford
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor / Q000037:antagonists & inhibitors; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors; D017277:Drug Approval; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000037:antagonists & inhibitors; D007371:Interferon-gamma / Q000037:antagonists & inhibitors; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D014157:Transcription Factors / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor; D004268:DNA-Binding Proteins; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; C118660:PDS5B protein, human; C505719:TNFSF13B protein, human; D014157:Transcription Factors; C511911:belimumab; D007371:Interferon-gamma